Subcutaneous vs Intravenous Trastuzumab for Patients With ERBB2-Positive Early Breast Cancer

标题
Subcutaneous vs Intravenous Trastuzumab for Patients With ERBB2-Positive Early Breast Cancer
作者
关键词
-
出版物
JAMA Oncology
Volume 5, Issue 5, Pages e190339
出版商
American Medical Association (AMA)
发表日期
2019-04-19
DOI
10.1001/jamaoncol.2019.0339

向作者/读者发起求助以获取更多资源

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now